Start Codon’s Post

Biotech is a rapidly growing industry, and investing in biotech startups offers a high potential for returns with the right strategy. In our latest article, we breakdown how Vibe Bio is making it easier for investors to overcome the risks & challenges. Read the full article here: https://lnkd.in/dVa-fxHx ____________________________________ #biotech #startups #investing #venturecapital #angelinvesting

A New Biotech Accelerator in Europe?... yes we have. 🚀 Sofinnova Partners is shaking things up in the biotech startup scene across Europe with their new investment strategy called Biovelocita. With Biovelocita, they've put together a top-notch team dedicated to providing hands-on support and financial backing to startups. This team brings a wealth of experience, including serial entrepreneurs and seasoned investors, who will collaborate with leading academic institutions. Key partners of this initiative include: - Maria Gabriella Camboni - co-founder and CEO of BiovelocITA - Matthieu Coutet - Partner with significant contributions to the launch of biotech startups such as Therachon and Annapurna Therapeutics - Alex Leech - founding CEO of Alchemab Therapeutics Ltd - Zhizhong "Joel" Y. - a former Principal in the Sofinnova Capital Strategy, and a Kauffman Fellows As one of the leading investors in Health Tech Europe, Sofinnova Partners continues to pave the way for innovation in the industry. Check out this article (👉 https://lnkd.in/eJ7PAaqG) for a glimpse into the top 25 most active investors in Health Tech in Europe, covering investments from Seed to Series A. 🌱💼 Enjoy the read! #Biotech #HealthTech #startups

Encouraging Signs for Medtech VC in Q1 2024 🚀 #medtech #venturecapital The medtech venture capital market roared back to life in the first quarter of 2024, with total investment reaching $3.3 billion according to the latest data from PitchBook. While deal volume remained historically low, this figure represents a strong rebound as investors piled into high-quality companies, signaling a keen focus on backing the most promising opportunities. #startup #funding The largest deal went to early cancer detection startup Freenome, which raised an impressive $254 million late-stage round led by Roche Venture Fund and Bain Capital Life Sciences. Other notable investments in the quarter included rounds for Impulse Dynamics, Mainstay Medical, Alamar Biosciences, and Medical Microinstruments. #biotechnology #oncology At $3.3 billion invested, Q1 2024 saw medtech VC activity reach a level not witnessed since Q4 2022 - providing a much-needed shot of optimism after a challenging few years for fundraising in the sector. However, it still lags behind the quarterly highs above $6 billion seen in 2021 during the VC boom years. #investment #venturecapital Looking at the overall landscape, Chicago's Tempus tops the list of top VC-backed medtech companies tracked by PitchBook, having raised a staggering $1.4 billion to date. #startups #entrepreneurs Read more: https://bit.ly/4dZoHH6

🔬✨ Thanks to everyone who joined our recent poll about the top challenges for biotech start-ups! Your insights are helpful for understanding our industry better. Looks like 40% of you think funding is the primary hurdle. No surprises there! Getting the cash flow needed isn't just about starting up; it's about keeping the innovation going, driving research forward, and getting life-changing products out there. At Ellab, we understand the critical role funding plays in the success of biotech ventures. That's why we're dedicated to supporting startups. From providing strategic advice on setup and ongoing compliance to save you valuable time and resources, to offering equipment rental options that spare you from large capital expenses while ensuring access to top-quality technology – we've got you covered. We're here to help you navigate the bumpy road from idea to market. Let us help you unlock the full potential of biotechnology. Get in touch with your local team to discuss any validation, monitoring, calibration or consultancy needs https://lnkd.in/eNp9CNph #Biotech #Startups #Funding #Innovation #Collaboration

As we look ahead to 2024, the biotech funding landscape is poised for evolution. ✨ Biotech startups have a range of funding avenues, all playing a pivotal role in fueling biotech innovation. Here's a glimpse: 🏢Government grants & public funding 💼Non-Government grants, 👤Private investment, 🦋Venture Capital, and 🤝Partnerships. You can guess our favorite. 😉 Accelerator programmes emerge as crucial catalysts. Programmes like ours offer not just funding but mentorship, resources, and a collaborative ecosystem, accelerating the path to success. 🙌 The biotech funding landscape is set for a thrilling evolution, and we 🦋 Labena Ventures are ready to be at the 😎 forefront of this dynamic journey. Join us on the fast track to groundbreaking discoveries! 📌 labenaventures.com/ Source: https://shorturl.at/qBELS . #startups #labenaventures #labena #accelerator #akcelerator #biotech #pharma #healthtech #food #founders #environment #bootcamp #investing #preseed #incubator #businessmentorship #cee #centralandeasterneurope #funding

Another huge impulse to our project. At DEBIOS Dx we've been awarded with the "StartUp Capital" grant from ACCIÓ The budget received gives us fuel to push the project, but it is much more than that. - It means the validation of our strategy (yes, strategy matters) - It means team recognition after S1 hard work (implementation is key) - It means we'll be able to securely initiate our clinical trial in liquid biopsy for #CKD - It means our team will start to grow, being able to hire top talented people to perform key activities. - It means business development, IP strengthening, etc. ...means a lot. Hopefully more traction for our open seed round. We've been ranked the second project on best valuation from an extensive list of amazing startups and spinoffs. Taking-off. Keep pushing. Keep following us. Do you want to become early-stage investor? Just drop us a message to know more at info@debiosdx.com #RenalCareMatters

🌐𝐒𝐨𝐟𝐢𝐧𝐧𝐨𝐯𝐚 𝐥𝐚𝐮𝐧𝐜𝐡𝐞𝐝 𝐧𝐞𝐰 𝐢𝐧𝐯𝐞𝐬𝐭𝐦𝐞𝐧𝐭 𝐬𝐭𝐫𝐚𝐭𝐞𝐠𝐲 𝐟𝐨𝐫 𝐚𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐢𝐧𝐠 𝐛𝐢𝐨𝐭𝐞𝐜𝐡 𝐬𝐭𝐚𝐫𝐭𝐮𝐩𝐬🧬 𝐈𝐧 𝐃𝐞𝐜𝐞𝐦𝐛𝐞𝐫 𝟐𝟎𝟐𝟑, Sofinnova Partners a Venture capital 💰firm opens up #biotech creation ‘toolbox’ as a part of #Europe-wide strategy aimed at setting up and accelerating #biotechstartups across Europe. The strategy dubbed with #Biovelocita involves, newly formed #team 🤝assembled with aim of providing hand on combining #directmanagement, #robust framework for startups, #financialbanking 💲and also access to #Sofinnova’s extensive #network 📶and infrastructure. To improve and expand its creation-toolbox, Sofinnova partnered with group of experienced #investors and #entrepreneurs. ▶𝐎𝐭𝐡𝐞𝐫 𝐫𝐞𝐥𝐚𝐭𝐞𝐝 𝐫𝐞𝐩𝐨𝐫𝐭:https://bit.ly/3uWv6AX #venturecapital #collaboration #buisnessstrategy #biotechcreation #biotech #prophecy #marketresearch #prophecymarketinsights

An inspiring kickoff to the Ontario Bioscience Innovation Organization (OBIO) Investment Summit meeting with the Honourable Nina Tangri, Associate Minister of Small Business for Ontario. We discussed ways to champion funding initiatives for small biotechs and bolster life science startups in our region. Together, we're looking for ways for local biotechs to beat the odds. #SmallBusiness #Biotech #Innovation #Collaboration #lifesciences #startups #ontariobusiness #OIS2024

#fundingalert 💼Company: Cellugy 💰Funding: €4.9 Million ⚡Round: Seed  👥Investors: ICIG Ventures, Unconventional Ventures led the round, which was also joined by new U.S.-based investor Joyance Partners, as well as existing investors PSV DeepTech, The Footprint Firm, and EIFO. Søborg-based Cellugy, a #Danish biotech firm, which has aspirations to expand #globally. From cellulose, the most abundant building element in nature, they developed superior material. The funding will also be used to support additional product co-development partnerships, which will enable #EcoFLEXY to expand its IP portfolio and headcount and enter new application areas. Isabel Álvarez-Martos, Pelin Yilmaz, Thea Messel, Deby Fapyane, Ph.D, Parun Sihombing, Dr. Andreas Worberg, Clara Capparelli Read more - https://lnkd.in/g3GKV9k9 To share your startup story write us on - contact@startuprise.co.uk #Cellugy #Biotechstartup #funding #fundingnews #startup #startupnews #startup #startuprise

🚀 Meet Our Advisors! We are excited to highlight that Nola E. Masterson, Venture Partner at Portfolia, as one of the esteemed advisors in our #H7 accelerator program. 👉 We are open for application for the 2024 Cohort of H7 Healthcare Accelerator, powered by H7 BioCapital. Early Bird Applications are open until 💥 July 30th 💥! 🦄 Apply for the Program: https://shorturl.at/TfJdB 🦄 Apply to Become Advisor: https://lnkd.in/eSbGpX28  📅 Early Bird Deadline: July 30th, 2024 🎯 About H7 Accelerator Program: https://lnkd.in/g3ycA8eE ------- 🎯Get to know our top-tier accelerator advisor - Nola E. Masterson "Nola has over 40 years of experience building and supporting biotech companies as an investor, entrepreneur, and consultant. She currently funds biotech ventures through Portfolia Femtech Funds. Her extensive background and commitment to advancing biotech innovation make her a key player in the industry." 🌷Apply now to learn invaluable insights from Nola E. Masterson and get connected with our 100+ industrial leading experts, pitch to top #investors, and scale your #startup! 🥳 Once you're selected for #H7 accelerator cohort, you'll be part of the #H7 community for life. Expand your business and expand your network with access to a talented group of founders, investors, mentors, and industry leaders. #accelerator #venturecapital #fundraising #healthcare #lifesciences #biotech #drugdevelopment #artificialintelligence #medicaldevices #hospitals #clinicaltrials #oncology #research #startup #founders #precisionmedicine #commercialization #sales #marketing #seed #angel